Seegene and Werfen to form a joint venture.

Seegene, a global molecular diagnostics company, and Werfen, a company specializing in diagnostic solutions, agreed to form a joint venture that will set up in Spain. "Over the past decade, our collaboration with Seegene has showcased the significant impact of their syndromic PCR diagnostic tests on healthcare. We are excited to leverage Seegene’s unparalleled technology and manufacturing expertise to develop products tailored for the Spanish and Portuguese market, where there is a high demand for rapid product development due to the frequent emergence of new infectious diseases and viral mutations. This partnership with Seegene will enable us to expand our footprint and respond swiftly to any outbreaks," Carlos Pascual, Werfen CEO.